/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / IMEL Biotherapeutics

IMEL Biotherapeutics

Company

IMEL Biotherapeutics is developing a novel mitochondrial replacement approach for cell-based therapies

Healthcare & Biotech

IMEL Biotherapeutics has 2 investors on file, among them Pontifax and Remiges Ventures. Its site was last checked 6 Nov 2026: site answers.

imelbiotx.com

Investors

2 investors on file
InvestorEvidenceType
PontifaxPortfolio pageVenture capital
Remiges VenturesPortfolio pageVenture capital

More from Pontifax

33 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (97%), AI & Machine Learning (3%).

AbcuroAbcuro develops therapies for autoimmune diseases and cancer.AdcendoAdcendo is developing a new generation of antibody-drug conjugates to …Adcytherix SASAdcytherix is building an antibody-drug conjugate powerhouse to advanc…Climb BioClimb Bio develops differentiated monoclonal antibodies for immune-med…Crystalys TherapeuticsCrystalys Therapeutics develops new therapeutics to address unmet medi…

See Pontifax's full profile · Who invests alongside it

More from Remiges Ventures

16 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (100%).

GlycomineGlycomine is developing replacement therapies for rare genetic disease…Immunis BiomedicalImmunis Biomedical is a clinical-stage biotech developing therapeutics…KupandoKupando develops therapies to address critical unmet medical needs in …Restore VisionRestore Vision develops a visual restoration gene therapyenemsapharma.comEnemsa Pharma develops therapies for neurodegenerative diseases

See Remiges Ventures' full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get IMEL Biotherapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Pontifax adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/imelbiotx.com/investors

# also
GET /v1/companies/imelbiotx.com
GET /v1/companies/imelbiotx.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing